Search Results 711-720 of 7618 for 谷歌搜索引擎留痕咨询邮箱:lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an ...
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been ...
The Meningeal Lymphatics and Neurological Disorders Laboratory led by Sandro Da Mesquita, Ph.D., collaborates with multiple Mayo Clinic researchers.
Mayo Clinic Rosa Parks Pavilion Building, BA-10NCR 200 First St. SW Rochester, MN 55905 · Email: migraineresearchprogram@mayo.edu ...
Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...
The purpose of this study is to evaluate a tele-rehabilitation service directed at treating upper limb weakness due to stroke to see if it is feasible to ...
About this study. The purpose of this study is to analyze the financial difficulties experienced by patients undergoing treatment for multiple myeloma (MM) ...
About this study. Patients with active Axial Spondyloarthritis without x-ray evidence of Ankylosing Spondylitis and with signs of inflammation will be ...
Biomarker-stratified and biomarker enrichment designs. Cluster randomized trial designs. Collection and analysis of adverse event data in oncology trials.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.